Skip to main content Skip to section navigation Skip to footer
Back to checkpointtx.com

Checkpoint Therapeutics, Inc.

Investor Relations
  • Investors
  • Overview
  • News & Events
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents

Press Releases

News & Events

News & Events

  • Press Releases
  • IR Calendar
  • Email Alerts
Mar 01, 2021

Checkpoint Therapeutics Announces Formation of Scientific Advisory Board

Jan 06, 2021

Checkpoint Therapeutics to Participate in Three January 2021 Virtual Investor Conferences

Nov 09, 2020

Checkpoint Therapeutics Announces Presentation of Updated Cosibelimab Lung Cancer Results at the Society for Immunotherapy of Cancer (SITC) 35th Anniversary Annual Meeting

Nov 04, 2020

Checkpoint Therapeutics Reports Third Quarter 2020 Financial Results and Recent Corporate Highlights

Sep 17, 2020

Checkpoint Therapeutics Announces $20.0 Million Bought Deal Offering

Sep 17, 2020

Checkpoint Therapeutics Announces Positive Interim Results from Registration-Enabling Trial of Cosibelimab in Metastatic Cutaneous Squamous Cell Carcinoma

Sep 10, 2020

Checkpoint Therapeutics to Participate in Three September 2020 Virtual Investor Conferences

Aug 17, 2020

Checkpoint Therapeutics to Present at Virtual Corporate Access Summit Hosted by B. Riley FBR on Wednesday, August 19, 2020

Aug 05, 2020

Checkpoint Therapeutics Reports Second Quarter 2020 Financial Results and Recent Corporate Highlights

Jul 27, 2020

Checkpoint Therapeutics to Present Cosibelimab Interim Results from Registration-Enabling Trial at ESMO Virtual Congress 2020

  • arrow_back
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • arrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
©2023 Checkpoint Therapeutics, Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap

Market Data copyright © 2023 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.